TARS

Tarsus Pharmaceuticals (TARS) Investor Questions

Tarsus Pharmaceuticals (TARS) investor questions: stock forecasts, price data, dividends, earnings dates, valuation and risk, with missing data clearly identified.

Research record updated: . Individual measures may refer to different reporting periods.

Company
Tarsus Pharmaceuticals
Sector
Healthcare
Industry
Biotechnology
Overall BTI score
76
Annual revenue
$451.36M
Annual net income
$-66.00M
Annual free cash flow
$-22.31M

Tarsus Pharmaceuticals (TARS) Investor Questions research

Tarsus Pharmaceuticals trades under the ticker TARS. The company is classified in the Healthcare sector and the Biotechnology industry.

Investors commonly review TARS through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.

What is Tarsus Pharmaceuticals (TARS) stock?

Tarsus Pharmaceuticals trades under ticker TARS. Its recorded sector is Healthcare. Its industry is Biotechnology.

What does the TARS stock forecast mean?

BTI's forecast summarizes available short-term and long-term research scores for TARS. These scores are not price targets, analyst consensus or probabilities of a positive return. Compare the Forecast, Earnings and Valuation pages before interpreting the outlook.

Where can I find the TARS stock price today?

Check the TARS quote and chart in the research workspace, including currency, trading session and quote timestamp. The research-record update time on this page is not a live quote timestamp.

Does TARS pay dividends?

Dividend yield is not supplied in this TARS research record. Missing data does not establish that Tarsus Pharmaceuticals does not pay dividends. Check the company's dividend announcements for declared amounts and dates.

When does TARS report earnings?

The available earnings record lists 2026-08-05 for TARS. This stored date may be historical; it is not confirmation of the next announcement. Check Tarsus Pharmaceuticals's investor-relations calendar for the current schedule; estimated dates can change.

How can I assess TARS's valuation and risk?

Compare Tarsus Pharmaceuticals's financial results, cash flow, debt and valuation assumptions with its operating risks and competitors. The Financials, Valuation and Statistics pages provide the available figures. A BTI score is a research input, not a personalized recommendation.